This on-demand activity is part of the Pharmacist to Pharmacist Buprenorphine Resource Initiative for Dispensing Guidance and Education (P2P BRIDGE) series. In this webinar, a panel of community pharmacists and buprenorphine prescribers discuss real-world cases and identify
red flags related to buprenorphine prescriptions along with strategies to resolve them. The goal of this activity, is to help community pharmacists better understand red flags and improve their decision-making process for buprenorphine dispensing to ensure both patient safety and benefit.
This webinar is a recording of a live broadcast presented on November 21, 2024, and has been edited for clarity. Participants who claimed CE for the live broadcast are not eligible to claim CE credit for the recorded webinar.
|
This ACPE-accredited continuing pharmacy education activity (0022-0000-24-023-H08-P) is designed to meet the Kentucky Board of Pharmacy continuing education regulatory requirement for pharmacists to complete 1 hour of CPE on the opioid epidemic or opioid use disorder as outlined in 201 KAR 2:0 |
Faculty Panel
![]() Nadia Ahmad, PharmD
Community Pharmacist
Walgreens
Pineville, KY
|
|
Nadia Ahmad is a passionate and dedicated Community Pharmacist who graduated in 2002 from the University of Punjab, Lahore, Pakistan, and has proudly served with Walgreens for the past 11 years. Currently, she works in the medically underserved community of Pineville, Kentucky. Her pharmacy career began in Pakistan, and she has worked across two vastly different healthcare systems. These diverse experiences have profoundly shaped her approach to patient care, allowing her to bring a unique global perspective to her role. With Walgreens, she has contributed to various initiatives, including Medication Therapy Management (MTM) services, leading immunization clinics, and fostering positive workplace cultures as the District Engagement Lead. Her work is driven by a desire to uplift both her team and the communities they serve. As the District Talent Acquisition Lead, she focuses on recruiting top pharmacy professionals to help address healthcare gaps in underserved areas. Additionally, she precepts pharmacy students during their community rotations, inspiring and guiding the next generation of pharmacists to embrace the rewards of a career in community pharmacy. Breaking the stigma surrounding mental health has become a central focus of Dr. Ahmad’s career, and she is proud to contribute to shaping a more compassionate and wellness-focused world.
|
|
![]() Kent L. Davis, MD, FAAFP, FASAM
Family Physician
Hopewell Family Medicine
Paris, KY
|
|
Kent L. Davis is a physician, board-certified in family and addiction medicine, who provides comprehensive care for all ages. He graduated from the University of Missouri-Kanas City School of Medicine and completed his residency training at the University of Kentucky. Dr. Davis started his private practice in Paris, Kentucky in 1983. He is also a physician staff member at Bourbon Community Hospital and Bourbon Heights Nursing Home in Paris, Kentucky. His medical practice remains independent from corporate influences and Dr. Davis strives to deliver personalized, relationship-driven, service in a family medicine atmosphere. The mission statement of his practice is "to treat all with compassion and competence". For the last 16 years, he has focused on evaluating and treating substance use disorders, especially opioid use disorder and its treatment. Since July 2017, he has served as the medical director for Recovery Works a community-based residential treatment facility for patients with substance use disorders located in Georgetown, Kentucky.
|
|
![]() Jeri Lynn Milwee, PharmD
Pharmacist
Bluegrass Care Navigators
Hazard, KY
|
|
Jeri Lynn Milwee is a pharmacist with 15 years of experience in Eastern Kentucky practicing in a variety of pharmacy settings including health system, community, and hospice. Dr. Milwee resides in Hazard with her husband and 9-year-old son. She is very passionate about patient care and providing pharmacy services to her community and neighbors. | |
![]() Melissa L. Zook, MD, FAAFP, FASAM, HIVS
Family Physician
London Women’s Care
London, KY
|
|
Melissa L. Zook is a family physician with London Women’s Care. She is board-certified in both family medicine and addiction medicine and is a certified HIV and Hepatitis specialist. She has integrated substance use disorder treatment into her primary care practice, providing primary, preventive, and specialty care to pregnant women, their partners, their families, and their neighbors since 2012. She has been a tireless advocate for increased access to medications for opioid use disorder in primary care in Kentucky, expanded harm reduction services, and improved access to care for persons with HIV and Hepatitis C in southeastern Kentucky. She has spoken and written frequently about her experiences as a modern country doctor. Dr. Zook most recently wrote about the importance of practicing harm reduction when caring for patients with substance use disorders and her own struggle embracing harm reduction practices. The chapter will appear in a larger anthology on Trust and Mistrust in Healthcare in Appalachia from the University of Tennessee Press in the Fall of 2024.
|
|
Moderator
Laura Stinson, PharmD
Academic Detailing Pharmacist
University of Kentucky Lexington, KY Content Reviewer
Courtney Eatmon, PharmD, BCPP
Clinical Pharmacist Practitioner, Substance Use Disorders
Lexington VA Health Care System
Lexington, KY
|
Disclosures
None of the faculty, planners, authors, reviewers, or others in control of educational content for this activity have any relevant financial relationships with ineligible companies to disclose.
Learning Objectives
- Discuss potential causes of delays and interruptions in buprenorphine therapy.
- Develop a decision-making process that balances patient care and corresponding responsibility.
- Examine the complexity involved in treatment decisions for opioid use disorder.
Agenda
- On-demand Webinar Presentation (80 min)
- Post-test and Evaluation (10 min)
Requirements for CE Credit
To claim credit for this activity, participants must:
1. Watch the on-demand webinar in its entirety
2. Pass the post-test with a score of 70% or higher
3. Complete the activity evaluation
Upon successful completion participant CE credit will be directly uploaded to CPE Monitor.
Fee
$0.00
CE Hours
1.50
CE Units
0.150
Activity Type
- Application
Target Audience(s)
- Pharmacists
Accreditation(s)

The University of Kentucky College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Support
The Buprenorphine Resource Initiative for Dispensing Guidance and Education (BRIDGE) is funded by a grant from the Foundation for Opioid Response Efforts (https://forefdn.org). For more information regarding P2P BRIDGE visit https://p2p.uky.edu/bridge.
System Requirements
Please ensure the computer system you plan to use meets the following minimum requirements:
- Operating System: Windows 10 or higher, macOS Sierra (10.12) or higher
- Internet Browser: Chrome 30 or higher, Firefox 27 or higher, Microsoft Edge, Safari 9 or higher
- Internet connection: Cable, High-speed DSL, and any other medium that is internet accessible
- Media Viewing Requirements: Adobe Reader, HTML5
Click to view our privacy policy
Education Disclaimer
The author(s) of this continuing education activity have made reasonable efforts to ensure that all information contained herein is accurate in accordance with the latest available scientific evidence at the time of publication. However, because information regarding medications, treatment guidelines, legal/regulatory issues and other healthcare information is subject to constant change, the participant is advised to always confirm practice resources before applying any learned information in practice. Activities accredited by the University of Kentucky College of Pharmacy are intended solely for purposes of supplementing health care professionals’ knowledge. The opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of The University of Kentucky College of Pharmacy.
For questions regarding this activity, please contact the UK CoP Continuing Professional Development Office at pharmacyCPD@uky.edu